Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
[Plants with antiviral properties used in Otorhinolaryngology].
Rev Med Inst Mex Seguro Soc
March 2024
Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Otorrinolaringología. Ciudad de México, México.
Viruses represent one of the main causes of human morbidity and mortality worldwide. Plants have been used since time immemorial to treat, cure or alleviate diseases. We present some of them that make compounds with antiviral action and are used in traditional medicine.
View Article and Find Full Text PDFSide-effects of Phytotherapeutics in Cancer Care - A Review of Inconsistencies in National and International Databases.
Anticancer Res
October 2024
Department of Internal Medicine II, Haematology and Internal Oncology, University Hospital Jena, Jena, Germany.
Background/aim: The interest in phytotherapy in patients with cancer is immensely high. When using herbal medicine, knowledge of potential side-effects is essential as part of counselling the patient. The aim of this study was therefore to collect information on the side-effects of popular medicinal plants and to compare different official and the most popular sources of information reporting the side-effects of phytotherapeutics.
View Article and Find Full Text PDFEfficacy and Hemorheology of Ginkgo biloba Extract (EGb 761) in the Treatment of Sudden Sensorineural Hearing Loss: A Retrospective Study.
Noise Health
September 2024
Department of Pharmacy, Wendeng Hospital of Traditional Chinese Orthopedics and Traumatology of Shandong Province, Weihai 264400, Shandong, China.
Objective: This study aimed to analyze the therapeutic effect of Ginkgo biloba extract (EGb 761) on sudden sensorineural hearing loss (SSNHL) and its influence on hemorheology.
Methods: The clinical data of patients diagnosed with SSNHL and admitted to the Wendeng Hospital of Traditional Chinese Orthopedics and Traumatology of Shandong Province from May 2020 to May 2023 were retrospectively analyzed. Based on different clinical treatment protocols, patients were divided into a control group (treated with routine treatment) and an administration group (treated with routine treatment + EGb 761).
Chinese herbal therapy in the management of rhinosinusitis-A systematic review and meta-analysis.
PLoS One
March 2023
China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.
This systematic review aims to assess the effects and safety of Chinese herbal medicines (CHMs) in the management of rhinosinusitis (RS); inform clinicians of the current state of the evidence; identify the best available evidence; and suggest further directions for research. Five English and four Chinese language databases, and four clinical trial registries were searched. Eligible studies were randomised controlled trials (RCTs).
View Article and Find Full Text PDFPhytomedicine ELOM-080 in Acute Viral Rhinosinusitis: A Randomized, Placebo-Controlled, Blinded Clinical Trial.
Laryngoscope
July 2023
Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
Background: ELOM-080 is a phytomedicine approved for the treatment of acute and chronic inflammatory diseases of the respiratory tract, sinusitis, and bronchitis in particular. This prospective, randomized, placebo-controlled, double-blind clinical trial was conducted to assess efficacy and safety of ELOM-080 in the treatment of acute viral rhinosinusitis (AVRS).
Methods: Patients with AVRS received oral treatment (4 × 1 capsule per day) with either ELOM-080 or matching placebo.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!